# Gene Solutions Lab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gene-solutions-lab

- Industry: Biotechnology
- Headquarters: Ho Chi Minh City, Vietnam
- Website: www.genesolutions.com
- Total disclosed funding: $21M
- Latest round: Series B (Sep 20, 2023)
- Investors on record: 1

## About

Based in Vietnam, Gene Solutions Lab LLC specializes in advanced genetic testing services that enhance healthcare through innovative genomics and artificial intelligence, primarily focusing on oncology and reproductive health solutions.Founded in 2018, Gene Solutions Lab LLC is located in Ho Chi Minh City, Vietnam. The company is focused on providing advanced genetic testing services and has successfully completed five deals. Their most recent funding round was a Series B round, raising USD 21.00 mn from Mekong Capital, which accounts for the total amount raised by the company.  The founder's previous entrepreneurial history is not detailed.Gene Solutions specializes in advanced genetic testing services aimed at enhancing healthcare across Asia through innovative multi-dimensional genomics and artificial intelligence (AI). Their core product offerings include the SPOT-MAS series for multi-cancer early detection and ctDNA-MRD testing for minimal residual disease monitoring, enabling timely interventions that can improve patient outcomes. Additionally, they provide genomic profiling services such as K-TRACK and K-4CARE, facilitating personalized treatment strategies. Their services are utilized by healthcare providers, hospitals, and research institutions in markets including Singapore, Indonesia, Malaysia, the Philippines, Thailand, and Vietnam.In the most recent year, Gene Solutions generated revenue of USD 3,301,215.70, with an EBITDA loss of USD 13,702,710.30. The company’s revenue stems primarily from offering its genetic testing services to healthcare professionals and institutions on a B2B basis.In January 2025, Gene Solutions Lab LLC raised an undisclosed amount of venture funding from new investor August Global Partners. The company will utilize this funding to develop its biotechnology platform. Moving forward, Gene Solutions plans to expand its product offerings and enter new markets, with specific targets not yet disclosed.

## Funding rounds

- Series B, Sep 20, 2023, $21M — Mekong Capital

## Investors

- Mekong Capital (https://capitalatlas.ai/funds/mekong-capital) — Series B